Testing two new drugs in healthy adults
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests how two new drugs (HODO-22251 and HODO-22252) interact with each other and how safe they are in healthy adults. It helps doctors understand the best way to give these drugs together.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 19 years old or older.
- You must be in good general health.
- Your body mass index (BMI) must be between 18.5 and 29.9.
- You must be willing to sign a consent form.
- You should not have any ongoing medical conditions that are not fully healed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how combining a ketone supplement with certain diabetes medicines affects blood sugar and ketone levels. It may help adults with type 2 diabetes who are not on insulin or certain other drugs.
This study tests a new pill called HDM1002 for adults with type 2 diabetes. It aims to see if it helps control blood sugar when added to your current metformin treatment.
This study tests a new medicine (HM11260C) to see if it helps people with type 2 diabetes who are already taking metformin and dapagliflozin but still have high blood sugar. If you qualify, it could give you a new option to better control your diabetes.
This trial tests the safety and how the body processes three common diabetes medications (dapagliflozin, linagliptin, and metformin) when taken together. Healthy volunteers are needed to help researchers understand how these drugs work in the body.
This study tests how the body handles three diabetes medicines (dapagliflozin, linagliptin, and metformin) when taken with food. It is for healthy volunteers to check safety and drug levels.
This study tests if a new medicine (elecoglipron) combined with dapagliflozin is safe and works better for adults with type 2 diabetes that isn't well controlled by diet or other medications.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.